Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect on Cytokines IL-1ß, TNF-α, IL-4 and Total Bacterial Load of an Oral Topical Composition Comprising Olive Oil, Trymethylglycine and Xylitol: a Randomized Controlled Double-blind Clinical Trial Part of the Stop Dysbiosis Project (SDP)

NCT06786910 is registered in ClinicalTrials.gov with Mucosa Innovations, S.L. as lead sponsor.

NCT NCT06786910
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06786910 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect on Cytokines IL-1ß, TNF-α, IL-4 and Total Bacterial Load of an Oral Topical Composition Comprising Olive Oil, Trymethylglycine and Xylitol: a Randomized Controlled Double-blind Clinical Trial Part of the Stop Dysbiosis Project (SDP)
Lead sponsor
Mucosa Innovations, S.L.
Phase
Not applicable
Overall status
Completed
Start date
June 13, 2022
Completion date
September 15, 2022
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bmi, chronic inflammatory diseases, cytokine levels, dysbiosis, inflammation, interleukin-1beta, overweight (bmi > 25), tnf-α